Silibinin has recently receive
d attention as a potential cancer chemopreventive agent because of itsantiproliferative an
d anticarcinogenic effects. A simple an
d specific reverse
d-phase high-performanceliqui
d chromatography metho
d was
develope
d an
d vali
date
d for the quantitation of silibinin in humanplasma. Sample preparation involve
d simple protein precipitation, an
d separation was achieve
d ona Waters Atlantis C
18 column with flow rate of 1.0 mL/min at 40
deg.gif">C an
d UV
detection at 290 nm.Silibinin was
detecte
d as two peaks correspon
ding to trans-
diastereoisomers. The peak area waslinear over the investigate
d concentration range (0-5000 ng/mL). The limits of
detection were 2 an
d1 ng/mL for the two
diastereoisomers (
d1 an
d d2), with a recovery of 53-58%. This metho
d wasutilize
d to
detect silibinin in plasma of colorectal patients after 7
days of treatment with silipi
de (silibininformulate
d with phosphati
dyl choline).